Backed by 26 ministries and GRADE evidence, PAHO’s new clinical pathway could accelerate access to SGLT2 inhibitors and statins to curb cardiorenal complications.
Medscape News Global
Source link : https://www.medscape.com/viewarticle/hearts-2-0-pahos-38-step-pathway-cardio-renal-care-2026a1000hk1?src=rss
Author :
Publish date : 2026-05-27 16:03:00
Copyright for syndicated content belongs to the linked Source.
